Log In
Print
BCIQ
Print
Print this Print this
 

MuDelta, eluxadoline (JNJ-270189066)

  Manage Alerts
Collapse Summary General Information
Company Furiex Pharmaceuticals Inc.
DescriptionLocally-acting mu opioid receptor agonist and delta opioid receptor antagonist
Molecular Target Mu opioid receptor (OPRM1) (MOR) ; Opioid receptor delta 1 (OPRD1) (DOR)
Mechanism of ActionMu opioid receptor agonist; Delta opioid receptor antagonist
Latest Stage of DevelopmentPhase III
IndicationIrritable bowel syndrome
Partner

Johnson & Johnson
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today